MYX 0.97% $5.11 mayne pharma group limited

New Product Approvals, page-30

  1. 10,435 Posts.
    lightbulb Created with Sketch. 1193
    We shouldnt jump the gun at the moment IMO.

    The known known is that sales will be down quite substantially.

    The unknown is how deep the cuts will be. Scott has already indcated there will be cost cuts..but we don't know what that will be however from stripping back R&D, no new product launches for the half and other such expensive items could see a substantial saving for the half that boosts the bottom line. However must do something out of the box with sales.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$5.11
Change
-0.050(0.97%)
Mkt cap ! $434.7M
Open High Low Value Volume
$5.20 $5.20 $4.85 $2.848M 571.8K

Buyers (Bids)

No. Vol. Price($)
2 1508 $5.03
 

Sellers (Offers)

Price($) Vol. No.
$5.11 1471 1
View Market Depth
Last trade - 16.10pm 28/05/2024 (20 minute delay) ?
Last
$5.07
  Change
-0.050 ( 1.77 %)
Open High Low Volume
$5.16 $5.16 $4.85 182397
Last updated 15.59pm 28/05/2024 ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.